Christina Ackermann - Sep 1, 2023 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-fact for Christina M. Ackermann
Stock symbol
VRNA
Transactions as of
Sep 1, 2023
Transactions value $
$0
Form type
4
Date filed
9/5/2023, 04:05 PM
Previous filing
Mar 27, 2023
Next filing
Apr 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Share Options (Right to Buy) Award $0 +144K $0.00 144K Sep 1, 2023 Ordinary Shares 144K $2.43 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 The option vests and becomes exercisable as to one-third of the underlying options on September 1, 2024 and the remainder in eight equal quarterly installments over the two years thereafter.